SALT LAKE
CITY, Nov. 4, 2013 /CNW/ - USANA Health Sciences
Inc. (NYSE: USNA) is building a state-of-the-art facility in
Beijing. The approximately $40 million
structure will house world-class manufacturing and production
operations. Upon completion, the nearly 319,000-square-foot site
will be the largest in all of USANA's 19 international markets.
(Logo:
http://photos.prnewswire.com/prnh/20120807/LA53885LOGO)
"Our plans to invest in a high-tech production facility in
Beijing reflect the significant
opportunity and potential we see for our business in mainland
China," said Dave Wentz,
USANA's chief executive officer. "At USANA, we demonstrate our
commitment to providing our customers with the highest quality
nutritionals by manufacturing essentially all of our products
in-house. This amazing facility will further that commitment."
USANA has negotiated land usage rights for this new building
with the Beijing Economic and Technological Development Area, which
houses a number of high-tech industries. The company anticipates
that construction on this facility will begin in 2014 and will be
operational during the latter part of 2015.
For more information about USANA's products and company, visit
USANA.com.
About USANA
Founded in 1992, USANA Health Sciences
(NYSE: USNA) is a U.S.-based nutritional company that manufactures
high-quality supplements and personal care, energy and
weight-management products in its FDA-registered facility in
Salt Lake
City. USANA's products, used by more than 600
professional athletes, are developed by the company's award-winning
team of scientists and sold directly to Preferred Customers and
Associates in 19 international markets. Learn more about USANA
(www.USANA.com) and stay current with the official USANA blog
(www.whatsupUSANA.com), like us on the USANA Facebook page
(www.facebook.com/USANAhealthsciences), or follow USANA on Twitter
(@USANAinc).
Safe Harbor
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Securities Exchange Act. Our
actual results could differ materially from those projected in
these forward-looking statements, which involve a number of risks
and uncertainties, including global economic conditions generally,
reliance upon our network of independent Associates, the
governmental regulation of our products, manufacturing and
marketing risks, adverse publicity risks, and risks associated with
our international expansion. The contents of this release should be
considered in conjunction with the risk factors, warnings, and
cautionary statements that are contained in our most recent filings
with the Securities and Exchange Commission.
Media Contact: Ashley Collins
Executive Director of PR, Social Media and Communications
USANA Health Sciences, Inc.
(801) 954-7629
media@us.usana(dot)com
SOURCE USANA Health Sciences Inc.